Delivery Order SPE2DB24D2100-SPE2DB24FBCSF

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,960.17, is for the supply of Advair HFA 230-21 mcg inhalers. It is a firm fixed-price delivery order with a performance period extending to May 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) for the supply of Advair HFA 230-21 MCG inhalers. The $1,533.01 fixed-price contract has an ultimate completion date of July 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,975.72 Firm Fixed Price contract is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a prescription respiratory medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,079.94, is for the delivery of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of September 9, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $14,618.85 contract is for the delivery of Advair HFA 230-21 MCG Inhaler, which is a prescription medication. The delivery order is a firm-fixed-price contract with a completion date of September 24, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $3,549.84 to Amerisourcebergen Drug Corp, a leading pharmaceutical distribution company, for the provision of Advair HFA 230-21 MCG Inhaler 12GM. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,147.89 firm fixed-price contract is for the delivery of Advair HFA 115-21 MCG Inhaler, 12 grams, with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 MCG Inhalers. The delivery order, valued at $1,083.18, is a firm fixed-price contract with a completion date of July 30, 2024. The award is not a set-aside contract. AmerisourceBergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG inhalers. The order has a firm fixed price of $2,302.49 and a completion date of August 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of medical commodities to support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Advair HFA 115-21 MCG inhalers. The $11,224.20 firm fixed-price contract has an ultimate completion date of July 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB24FBCSF
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG Inhaler 12GM. The $3,099.87 firm-fixed-price contract has a completion date of July 31, 2024 and is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This delivery order falls under that broader IDC vehicle, enabling DLA to efficiently procure the needed pharmaceutical product from the experienced federal contractor.

Generated 10/29/24, 9:19 AM